The global chronic hepatitis B treatment market is experiencing significant growth. This phenomenon can be connected to a growing of factors, including an increasing population, enhanced diagnostic capabilities, and growing awareness about the disease. The market is moreover driven by innovations in treatment approaches, such as antiviral therapies